n Obstetrics and Gynaecology Forum - Trastuzumab (Herceptin) for the diagnosis and treatment of breast cancer : a review : review article
|Article Title||Trastuzumab (Herceptin) for the diagnosis and treatment of breast cancer : a review : review article|
|© Publisher:||In House Publications|
|Journal||Obstetrics and Gynaecology Forum|
|Author||L.J. Van Bogaert|
|Publication Date||Oct 2008|
|Pages||139 - 142|
|Keyword(s)||Breast cancer, Targeted therapy and Trastuzumab|
The emergence of targeted therapy for cancer, and more especially for breast cancer, has created high expectations from patients and oncologists. Trastuzumab, better known as Herceptin, is used for the diagnosis and treatment of tumours carrying the HER-2 oncogene. From the diagnostic point of view, all methods for the assessment of the HER-2 gene or the HER-2 protein have limitations in terms of both technology and cut-off values and have not yet been standardized. Both false positive and false negative assessments are currently not uncommon. The inclusion criteria for treatment with trastuzumab are relatively narrow and the cost per cure is, at present, extremely high. It is therefore essential to have an understanding of the current data about this therapy and of their interpretation.
Article metrics loading...